Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Diabetic Macular Edema Treated with Anti–Vascular Endothelial Growth Factor: Considerations Related to Nonimprovers

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Outcomes of Diabetic Macular Edema Patients by Baseline Hemoglobin A1c: Analyses from VISTA and VIVID

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Melanopsin-mediated pupillary light reflex and sleep quality in patients with normal tension glaucoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Optos wide-field imaging versus conventional camera imaging in Danish patients with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Evaluating an algorithm for screening intervals for diabetic retinopathy and the effect of HbA1c and hypertension

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  4. Evaluation of a screening algorithm for detection of diabetic retinopathy based on quantitation of retinal pathological elements

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations
Purpose To investigate central subfield thickness (CST) nonimprovers’ anatomic response in macular areas outside the central subfield and the time course of this response. Furthermore, to investigate the relationship between peripheral improvement and visual acuity. Design Retrospective study. Participants A total of 566 eyes in 566 patients with center-involved diabetic macular edema who initiated intravitreal treatment with ranibizumab between January 1, 2011 and December 31, 2013 in the Greater Copenhagen Region. Follow-up was completed at 2 years. Methods Patients were initially grouped as CST improvers and CST nonimprovers. The CST improvers had a ≥10% reduction in CST on ≥1 visit as opposed to CST nonimprovers with
Original languageEnglish
JournalOphthalmology Retina
Volume2
Issue number11
Pages (from-to)1133-1142
Number of pages10
ISSN2468-6530
DOIs
Publication statusPublished - Nov 2018

ID: 55656624